The association between birthweight and perinatal mortality risk in gestational diabetes pregnancies: A retrospective cohort study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background In the general obstetric population the lowest perinatal mortality risk for babies occurs between the 75th and 90th growth percentiles, and as birthweights decrease below this level perinatal risk increases. No study has yet explored risk versus birthweight percentile for Gestational Diabetes pregnancies so the primary aim of this study is to evaluate this relationship. Methods Using data from a large perinatal data collection in the Australian State of Queensland, babies born between 2010 and 2023 from 92,621 singleton gestational diabetes pregnancies between 24 and 42 weeks gestation were stratified into six birthweight percentile categories for which stillbirth and neonatal mortality rates were compared and odds ratios for mortality calculated using multivariable logistic regression and adjusting for multiple potential confounders. The reference category was the 75th to 90th percentile group. Mortality rates were also compared after adjusting for death to delivery intervals of two and five days and for the presence or absence of congenital abnormalities. Results The lowest mortality risk occurred for babies in the 75-90 th birthweight percentile group, and mortality risk increased as birthweights decreased below this level. With reference to the 75-90 th percentile, Odds Ratios for mortality by group were :- 25-<75%, 2.01(95%CI 1.32-3.17); 10-<25%, 2.71(95%CI1.64-4.54); <10%, 7.77(95%CI 4.99-12.5); 90-<97%, 1.37(95%CI 0.76-2.47); and >=97%, 2.55(95%CI 1.42-4.54). After adjustments for death-to-delivery intervals of two and five days and for the presence or absence of congenital abnormalities larger babies remained at lower risk than babies below the 25 th percentile. Conclusion In the absence of evidence from prior studies of significant treatment benefit for babies, the observed association of increasing mortality with decreasing birthweight for the majority of babies of treated gestational diabetes pregnancies should spark debate about the current practice of medically, and particularly pharmacologically, restricting the growth of these babies.
Source: Research Square
Institutions: Mater Mothers' Hospital, Queensland Health
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235139725
